NasdaqGS - Delayed Quote • USD
Inari Medical, Inc. (NARI)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:29 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
493,632.00
493,632.00
383,471.00
276,984.00
139,670.00
Cost of Revenue
59,068.00
59,068.00
44,506.00
24,757.00
13,106.00
Gross Profit
434,564.00
434,564.00
338,965.00
252,227.00
126,564.00
Operating Expense
448,596.00
448,596.00
367,064.00
241,383.00
108,145.00
Operating Income
-14,032.00
-14,032.00
-28,099.00
10,844.00
18,419.00
Net Non Operating Interest Income Expense
15,417.00
15,417.00
1,558.00
-141.00
-651.00
Other Income Expense
2,861.00
2,861.00
356.00
-18.00
-3,979.00
Pretax Income
4,246.00
4,246.00
-26,185.00
10,685.00
13,789.00
Tax Provision
5,882.00
5,882.00
3,082.00
845.00
--
Net Income Common Stockholders
-1,636.00
-1,636.00
-29,267.00
9,840.00
13,789.00
Diluted NI Available to Com Stockholders
-1,636.00
-1,636.00
-29,267.00
9,840.00
13,789.00
Basic EPS
-0.03
-0.03
-0.55
0.20
0.43
Diluted EPS
-0.03
-0.03
-0.55
0.18
0.27
Basic Average Shares
56,770.66
56,770.66
52,837.67
49,815.91
32,033.83
Diluted Average Shares
56,770.66
56,770.66
52,837.67
55,594.16
51,555.00
Total Operating Income as Reported
-14,032.00
-14,032.00
-28,099.00
10,844.00
18,419.00
Total Expenses
507,664.00
507,664.00
411,570.00
266,140.00
121,251.00
Net Income from Continuing & Discontinued Operation
-1,636.00
-1,636.00
-29,267.00
9,840.00
13,789.00
Normalized Income
-1,636.00
-1,636.00
-29,267.00
9,840.00
17,106.00
Interest Income
15,613.00
15,613.00
1,852.00
154.00
484.00
Interest Expense
196.00
196.00
294.00
295.00
1,135.00
Net Interest Income
15,417.00
15,417.00
1,558.00
-141.00
-651.00
EBIT
4,442.00
4,442.00
-25,891.00
10,980.00
14,924.00
EBITDA
15,177.00
15,177.00
-18,772.00
15,288.00
16,309.00
Reconciled Cost of Revenue
59,068.00
59,068.00
44,506.00
24,757.00
13,106.00
Reconciled Depreciation
10,735.00
10,735.00
7,119.00
4,308.00
1,385.00
Net Income from Continuing Operation Net Minority Interest
-1,636.00
-1,636.00
-29,267.00
9,840.00
13,789.00
Total Unusual Items Excluding Goodwill
--
--
--
--
-3,317.00
Total Unusual Items
--
--
--
--
-3,317.00
Normalized EBITDA
15,177.00
15,177.00
-18,772.00
15,288.00
19,626.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
12/31/2020 - 5/22/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PEN Penumbra, Inc.
204.41
-0.53%
SWAV Shockwave Medical, Inc.
330.00
+0.31%
TMDX TransMedics Group, Inc.
92.08
+3.17%
CNMD CONMED Corporation
65.78
+6.27%
PODD Insulet Corporation
166.19
+1.23%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
IART Integra LifeSciences Holdings Corporation
28.34
-0.25%
NVCR NovoCure Limited
12.64
+3.31%
EW Edwards Lifesciences Corporation
86.43
-1.80%
SILK Silk Road Medical, Inc
17.80
+0.85%